Related Experiment Video
Updated: Jul 4, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Wu Lin1, Yuxiang Yan2, Qingling Huang1
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, People's Republic of China.
Abstract:
The p53 tumor suppressor protein plays an important role in physiological and pathological processes. MDM2 and its homolog MDMX are the most important negative regulators of p53. Many studies have shown that MDMX promotes the growth of cancer cells by influencing the regulation of the downstream target gene of tumor suppressor p53. Studies have found that inhibiting the MDMX-p53 interaction can effectively restore the tumor suppressor activity of p53. MDMX has growth-promoting activities without p53 or in the presence of mutant p53. Therefore, it is extremely important to study the function of MDMX in tumorigenesis, progression and prognosis. This article mainly reviews the current research progress and mechanism on MDMX function, summarizes known MDMX inhibitors and provides new ideas for the development of more specific and effective MDMX inhibitors for cancer treatment.
Insights
Targeting MDMX, a key regulator of the p53 tumor suppressor, shows promise for cancer treatment. Inhibiting the MDMX-p53 interaction can restore p53
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The p53 tumor suppressor protein is crucial in cellular regulation.
- MDM2 and MDMX are primary negative regulators of p53.
- MDMX promotes cancer cell growth by inhibiting p53 activity.
Purpose of the Study:
- To review current research on MDMX function in tumorigenesis.
- To summarize MDMX inhibitors and their mechanisms.
- To propose strategies for developing novel MDMX inhibitors.
Main Methods:
- Literature review of studies on MDMX and p53 interactions.
- Analysis of the role of MDMX in cancer progression.
- Summary of existing MDMX inhibitor data.
Main Results:
- MDMX inhibition restores p53 tumor suppressor activity.
- MDMX promotes cancer growth independently of wild-type p53.
- Targeting MDMX-p53 interaction is a viable therapeutic strategy.
Conclusions:
- Understanding MDMX function is critical for cancer treatment.
- Developing specific MDMX inhibitors offers a promising avenue for cancer therapy.
- Further research into MDMX inhibitors can lead to more effective cancer treatments.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Epigenetic Regulation

